Do inflammatory cytokines alter the HPA axis and reduce adrenal DHEA production?

Chronic inflammatory signaling, characterized by the elevation of pro-inflammatory cytokines, significantly alters the hypothalamic-pituitary-adrenal (HPA) axis and redirects adrenal hormone synthesis. Research shows that cytokines like IL-1β, TNF-α, and IL-6 serve as potent triggers for HPA activation while simultaneously impairing the production of adrenal androgens like DHEA and DHEA-S.

Clinical evidence and adrenal shunting

During states of systemic inflammation or chronic illness, the body shifts its steroid production priorities.

• Metabolic Shunting: Inflammatory cytokines promote a "metabolic shunt" where the adrenal glands prioritize the production of life-sustaining cortisol over DHEA. This shift is clearly observed in chronic inflammatory conditions and acute physiological stress, resulting in a significantly elevated cortisol-to-DHEA-S ratio.
• Clinical Correlates: In a study of women with autoimmune conditions, elevated levels of IL-6 were strongly associated with lower circulating DHEA-S. This androgen deficiency is linked to reduced muscle mass, fatigue, and impaired mood, particularly in women over 40 whose androgen levels are already naturally declining.

Mechanistic explanations

The reduction of DHEA is not merely a byproduct of stress but a specific molecular inhibition of the adrenal enzyme machinery.

• Enzymatic Inhibition: Pro-inflammatory cytokines (TNF-α and IL-1β) selectively inhibit the 17,20-lyase activity of the enzyme CYP17A1 in the adrenal zona reticularis. This specific step is required to convert precursors into DHEA.
• NF-κB and JAK/STAT: Signaling pathways like NF-κB and JAK/STAT downregulate the transcription of CYP17A1 and its essential cofactor, cytochrome b5, directly reducing the adrenal gland's capacity to synthesize androgens.
• Glucocorticoid Resistance: While cytokines initially stimulate cortisol production, chronic exposure leads to glucocorticoid receptor (GR) resistance. This means that despite high cortisol levels, the HPA axis fails to "turn off" the inflammatory response, creating a feed-forward loop that continues to suppress DHEA synthesis.

Bidirectional feedback and implications

• Loss of Immunomodulation: DHEA-S normally acts as a mild anti-inflammatory agent, inhibiting the production of TNF-α and IL-8. When cytokines suppress DHEA, this protective feedback is lost, potentially worsening the inflammatory state.
• Potential Reversibility: Emerging research indicates that mind-body interventions and regular moderate exercise may help normalize HPA-immune dysregulation by lowering systemic cytokine levels and potentially restoring the cortisol-to-androgen balance.

Bottom line

Inflammatory cytokines disrupt the HPA axis by inducing glucocorticoid resistance and selectively inhibiting the 17,20-lyase activity of CYP17A1. This results in a "shunting" effect where cortisol is produced at the expense of DHEA, leading to an androgen-depleted state that can perpetuate inflammation and fatigue.